Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Zhang

Showing results (211-220 of 215) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 215 results.
ACS Medicinal Chemistry Letters|June 22, 2016
Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective AgonistYan Shi, Jun Li, Lawrence J Kennedy, et al.
Journal of Medicinal Chemistry|August 29, 2014
Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidateWilliam N Washburn, Mark Manfredi, Pratik Devasthale, et al.
Journal of Medicinal Chemistry|March 12, 2010
Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)Jun Li, Lawrence J Kennedy, Yan Shi, et al.
Journal of Medicinal Chemistry|October 28, 2021
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA<sub>1</sub>) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic DiseasesPeter T W Cheng, Robert F Kaltenbach, Hao Zhang, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 4, 2024
2023 Canadian Surgery Forum: Sept. 20-23, 2023Raphaëlle Brière, Marce Émond, Axel Benhamed, et al.
Pageof 22

Showing results (211-220 of 215) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 215 results.
ACS Medicinal Chemistry Letters|June 22, 2016
Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective AgonistYan Shi, Jun Li, Lawrence J Kennedy, et al.
Journal of Medicinal Chemistry|August 29, 2014
Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidateWilliam N Washburn, Mark Manfredi, Pratik Devasthale, et al.
Journal of Medicinal Chemistry|March 12, 2010
Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)Jun Li, Lawrence J Kennedy, Yan Shi, et al.
Journal of Medicinal Chemistry|October 28, 2021
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA<sub>1</sub>) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic DiseasesPeter T W Cheng, Robert F Kaltenbach, Hao Zhang, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 4, 2024
2023 Canadian Surgery Forum: Sept. 20-23, 2023Raphaëlle Brière, Marce Émond, Axel Benhamed, et al.
Pageof 22